Revealing the genomic drivers of pathogen virulence, adaptation, and immunity with HiFi sequencing

Meredith Ashby has been with Pacific Biosciences since 2009, initially working in R&D on both sequencing integration and bioinformatics application development before joining the marketing team to work on an array of research areas including human population genomics, cancer research, immunology, and microbiology. She is now focused on facilitating the use of PacBio long read sequencing to solve the unmet needs of scientists seeking to understand the incredibly diverse range of microbes that live in, on and around us and the complex systems we depend on. She has been actively engaged in PacBio’s response to the global COVID-19 pandemic, including the forthcoming release of a SARS-CoV-2 sequencing kit.